Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study
Lee TTM, Collett C, Bergford S, et al.
Lancet Diabetes Endocrinol. Pub. online 27 Jan 2025.
Leggi
Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes
Shen J, Sarwal A, Singh R, et al.
Diabetes Obes Metab. Pub. online 30 Jan 2025.
Leggi
Islet autoantibody screening throughout Australia using in-home blood spot sampling: 2-year outcomes of Type1Screen
Wentworth JM, Sing ABE, Naselli G, et al.
Diabetes Care. 2025:dc242443.
Leggi
Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021
Chen X, Zhang L, Chen W
BMC Med. 2025;23(1):48.
Leggi
Decision-making behavior of blood glucose management and its influencing factors in pregnant women with gestational diabetes mellitus
Xu S, Wang J, Wang Y, et al.
BMC Pregnancy Childbirth. 2025;25(1):83.
Leggi
Impact of time in tight range on all-cause and cardiovascular mortality in type 2 diabetes: a prospective cohort study
Cai J, Liu J, Lu J, et al.
Diabetes Obes Metab. Pub. online 27 Jan 2025.
Leggi
I AMD Family – Riflessioni sull’indirizzo societario, sul posizionamento attuale e futuro di AMD | 5 febbraio 2025 – Roma
Leggi
Diabetes risk after treatment for childhood and young adult cancer
Cromie KJ, Murray RD, Ajjan RA, et al.
Diabetes Care. 2025:dc242171.
Leggi
AIFA: ll CdA AIFA approva la rimborsabilità, in tutte le Regioni, del farmaco BAQSIMI (glucagone spray nasale) e di due farmaci per il trattamento del diabete mellito (MOUNJARO e AWIQLI)
29/01/2025
Leggi
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial
Liu Y, Chen Y, Ma J, et al.
BMJ. 2025;388:e081820.
Leggi